Cedars-Sinai account plan
Leading healthcare, research, education
At a glance
Cedars-Sinai is a Los Angeles nonprofit academic health system with three hospital groups and $8,586,547 thousand of FY2025 revenues.
Cedars-Sinai Health System is a California nonprofit, tax-exempt academic health system and the sole corporate member of Cedars-Sinai Medical Center, Torrance Memorial and Huntington Hospital in the Los Angeles area, providing patient care, medical research, health education and community service. Commercial and managed care is by far its largest payer class. In FY2025 (year ended June 30, 2025) total revenues, gains and other support were $8,586,547 thousand and income from operations fell to $238,931 thousand, while investment income lifted the excess of revenues over expenses to $852,165 thousand. It runs one of the 10 largest hospital-based research programs in America; Dr. Peter Slavin is president and CEO.
Business units
Cedars-Sinai Medical Center
919 licensed bedsThe flagship hospital in Los Angeles, providing patient care, medical research, health education and community service, with more than 2,100 physicians. It holds a 49% interest in Providence Tarzana Medical Center, a joint venture with Providence St. Joseph Health.
Cedars-Sinai Medical Care Foundation
The physician enterprise operating primary care, specialty and multispecialty clinics and holding payer contracts and acquired physician practices.
Cedars-Sinai Marina Hospital
103 licensed bedsA community hospital controlled by Cedars-Sinai Medical Center.
Torrance Memorial Health System
610 licensed bedsTorrance Memorial Medical Center, a general acute care hospital serving the South Bay community with inpatient, outpatient and emergency care, plus its fundraising foundation.
Huntington Hospital
534 licensed bedsA general acute care hospital in Pasadena serving the San Gabriel Valley, with Huntington Health Physicians providing care through contracted medical groups.
Third Street Insurance Company
Wholly owned captive insurer domiciled in Bermuda, funding the self-insured portion of professional and general liability since July 1, 2022.
Strategic priorities
- Accelerating Excellence programme
- A top-to-bottom initiative to "grow revenue, reduce expenses, and come up with a game plan with respect to those headwinds before they hit".
- Operating efficiency and access
- More efficient operating rooms, shorter hospital stays and wider access to outpatient locations.
- Philanthropy growth
- Grow the philanthropic programme, which the CEO says has grown significantly but has "significantly more potential".
- Commercialising research
- Commercialise intellectual property from one of the 10 largest hospital-based research programs in America, including co-creating digital health companies with Redesign Health.
- Digital care and international presence
- Virtual platforms CS Link and CS Connect, ambient documentation for physicians and inpatient nurses, and a first flagship outpatient clinic outside the U.S. in London with Guy's and St Thomas'.
Investments and deals
- Facilities capital programme
- Expenditures for property and equipment of $657,770 thousand in FY2025, up from $474,013 thousand, with construction-in-progress reaching $1,065,249 thousand, mostly buildings.
- Software and cloud systems
- Gross property includes $1,141,200 thousand of software and software implementation costs, and the system capitalises cloud hosting implementation costs.
- Providence Tarzana joint venture
- 49% interest in Tarzana Medical Center, LLC with Providence St. Joseph Health; capital contributions totalled $335,228 thousand at June 30, 2025.
- London clinic
- First clinical presence outside the U.S., a flagship outpatient clinic in London run in partnership with Guy's and St Thomas'.
Challenges and risks
- Payer mix deterioration
- The CEO expects patients covered by government programs to become uninsured as enhanced ACA tax credits expired and Medicaid cuts under HR1 unfold, with "a significant impact on our finances".
- Costs rising faster than revenue
- Total expenses rose to $8,347,616 thousand in FY2025, with salaries and related costs of $4,161,181 thousand, cutting income from operations from $328,909 thousand to $238,931 thousand.
- Research funding uncertainty
- The CEO sees "some wobble in Washington, D.C., around enthusiasm for supporting biomedical research".
- Litigation
- Wage-and-hour class actions and PAGA claims, and 2024 litigation against an obstetrics and gynecology physician and Cedars-Sinai Medical Center that "may have a material impact on Cedars-Sinai's financial position".
What leadership says
“We don't want to wait until we're underwater and have to do some desperate things.”
“We're trying to grow our philanthropic program. It's grown significantly in recent years, but we think there's significantly more potential to turn to philanthropists and ask them to support our mission”
“We are rolling out ambient documentation for physicians, and something similar for inpatient nurses, so they can reduce documentation time and spend more time with patients.”
Where a supplier can help
- Operating room and length-of-stay efficiency
- The Accelerating Excellence levers on OR efficiency and shorter stays create demand for capacity management, patient flow and perioperative analytics.
- Clinical documentation AI
- The rollout of ambient documentation for physicians and inpatient nurses opens room for AI documentation and workflow vendors that cut clinician time.
- Outpatient and virtual access
- Wider outpatient access and the CS Link and CS Connect platforms point to needs in scheduling, virtual care and patient access tools.
- Construction and facilities
- Construction-in-progress of $1,065,249 thousand at June 30, 2025, mostly buildings, tied to the facilities capital programme, suits construction, medical equipment and facilities-management suppliers.
- Revenue cycle under payer pressure
- With payer mix expected to worsen, revenue cycle, eligibility and cost-reduction services address a stated challenge.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Cedars-Sinai?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Cedars-Sinai Health System Consolidated Financial Statements and Uniform Guidance Report, Years Ended June 30, 2025 and 2024
- Cedars-Sinai Health System is a California nonprofit, tax-exempt academic health system and sole corporate member of Cedars-Sinai Medical Center, Torrance Memorial (Torrance Health Association) and Huntington Hospital (Pasadena Hospital Association); audited by Ernst & Young for the years ended June 30, 2025 and 2024.
- FY2025 total revenues, gains and other support of $8,586,547 thousand (FY2024: $8,208,279 thousand); net patient service revenues $7,415,712 thousand, premium revenues $401,534 thousand.
- Income from operations fell to $238,931 thousand from $328,909 thousand as total expenses rose to $8,347,616 thousand (salaries and related costs $4,161,181 thousand); investment income of $601,727 thousand lifted the excess of revenues over expenses to $852,165 thousand.
- Payer mix of net patient service revenues: commercial and managed care $5,465,268 thousand, Medicare $1,602,157 thousand, Medi-Cal $154,150 thousand (down from $304,631 thousand); inpatient services 59% of charges, outpatient 41%.
- Balance sheet of $17,407,802 thousand total assets and $12,487,004 thousand net assets; long-term debt $2,485,907 thousand; $7,587,591 thousand of financial assets available for general use within one year.
- Heavy capital programme: expenditures for property and equipment of $657,770 thousand in FY2025 (FY2024: $474,013 thousand); construction-in-progress rose to $1,065,249 thousand, mostly buildings.
- Research and community role: $201,798,468 of federal award expenditures in the year; unreimbursed cost of care of the poor and community benefit approximately 22.0% of total operating expenses, total community benefit $1,510,373 thousand.
- Risks flagged: wage-and-hour class actions and PAGA claims, and 2024 litigation against an obstetrics and gynecology physician and Cedars-Sinai Medical Center that "may have a material impact" on Cedars-Sinai's financial position; Medicare/Medi-Cal regulatory and audit exposure.
- Cedars-Sinai CEO talks about meeting financial challenges at ViVE 2026
- Dr. Peter Slavin, president and CEO of Cedars-Sinai, says the financial headwinds facing nonprofit and academic health systems are "probably more ominous than I've ever seen in my career in healthcare management".
- He expects patients now covered by government programs to become uninsured as ACA enhanced tax credits expired and Medicaid cuts under the HR1 tax package unfold, with "a significant impact on our finances".
- Cedars-Sinai launched an initiative called "Accelerating Excellence" to grow revenue, reduce expenses and plan for the headwinds before they hit.
- Concrete levers: more efficient operating rooms, shorter hospital stays, and wider access to outpatient locations.
- Growing philanthropy is a priority: the programme has grown significantly and he sees "significantly more potential".
- Commercializing intellectual property from one of the 10 largest hospital-based research programs in America is another revenue lever.
- His advice to peers: "never take your eye off the ball" and "don't wait until the storm has hit".
- Interview: Dr. Peter L. Slavin, Cedars-Sinai
- Dr. Peter L. Slavin, CEO of Cedars-Sinai (formerly at Mass General), says the challenge for academic medical centers is now "to maintain financial stability as revenue growth slows and costs continue to rise".
- Cedars-Sinai's main medical center is described as having 886 licensed beds and more than 2,100 physicians.
- International growth: Cedars-Sinai has opened its first flagship outpatient clinic outside the U.S., in London, in partnership with Guy's and St Thomas'; it has administrative offices in Mexico City, Singapore and London.
- Digital: virtual platforms CS Link and CS Connect; ambient documentation is being rolled out for physicians and something similar for inpatient nurses.
- Investment choices follow clinical need (e.g. cancer care as the population ages) and scientific opportunity.
- Commercialization: a long history of spinning off companies, and a partnership with Redesign Health to co-create digital health companies.
- Slavin calls the U.S. system "a very broken system" because of insurance complexity, and says research funding in Washington has "some wobble".
Questions about Cedars-Sinai
What is Cedars-Sinai?
Cedars-Sinai Health System is a Los Angeles nonprofit academic health system made up of Cedars-Sinai Medical Center, Torrance Memorial and Huntington Hospital, with a large research programme.
What is Cedars-Sinai's revenue?
Total revenues, gains and other support were $8,586,547 thousand in FY2025 (year ended June 30, 2025), of which net patient service revenues were $7,415,712 thousand.
Who leads Cedars-Sinai?
Dr. Peter Slavin, formerly at Mass General, is president and CEO.
What is Cedars-Sinai's strategy?
Its Accelerating Excellence initiative aims to grow revenue and reduce expenses ahead of Medicaid and ACA headwinds, through operating efficiency, outpatient access, philanthropy and research commercialisation.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)